SSRI Antidepressant Medications: Adverse Effects and Tolerability
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been routinely identified to cause less severe withdrawal effects than other SSRIs, which has been attributed to its longer half-life 3,30,75 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However many of these drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
From Molecular and anatomical organization of the dorsal raphe nucleus (2019) · cites this paper as Ferguson, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During long-term use of SSRIs, the most troubling adverse effects seem to be gastrointestinal problems, sleep disturbances and sexual dysfunction,49”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“often intolerable side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many patients refusing to take traditional antidepressants due to their side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 497
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder: A Controlled Trial
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., & Lelliott, P. T. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 201
Cited by
Items 501–600 of 670
Mental Health Interventions for the Elderly
Mikesell, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-12852-4_8-1 · Cited by 3
Grant, A. D., Erfe, M. C. B., Delebecque, C. J., Keller, D. L., Zimmerman, N. P., Kazaryan, A., Oliver, P. L., Moos, J., Luna, V., & Craft, N. (2025) · medRxiv · doi:10.1101/2025.04.14.25325830 · Cited by 3
The risks versus the benefits of pharmacological intervention in social anxiety disorder in children
Hofmann, S. G., Kasch, C., Pereira, B., Barbosa, C., & Andreoli, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461763 · Cited by 2
“Among these concerns is the association between this kind of intervention and the risk of depression and suicidality [73].”
National patterns of paroxetine use among US Medicare patients from 2015–2020
Cavanah, L. R., Goldhirsh, J. L., Huey, L. Y., & Piper, B. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1399493 · Cited by 5
“Despite their name, SSRIs often have activity on other chemicals, which can contribute to adverse effects (5, 6), and the unique differences in receptor pro fi les may help guide a clinician ’ s preference for a particular clinical situation or patient population.”
BackgroundDewar-Haggart, R., Müller, I., Bishop, F. L., Geraghty, A. W. A., Stuart, B. L., & Kendrick, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0299676 · Cited by 3
Akwan, R., Elsharkawy, M. M., Zrineh, A., Amleh, A., Douden, B., Alhouseini, M., Alsaeed, L., & Eldesouki, M. H. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03904-9 · Cited by 2
“These include troublesome side effect profiles (weight fluctuations, sexual dysfunction, sleep disturbances), treatment resistance, delayed onset of action, and overall modest efficacy [16–19].”
Drange, S., Cohen, J., Johansen, S. S., Dunkley, B. T., & Palner, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1819962 · Cited by 2
Neuroactive drugs–A perspective on drugs of synthetic and medicinal plants origin
Shaikh, M. F., Arulsamy, A., Jaiswal, Y. S., Goh, B. H., Bhuvanendran, S., Retinasamy, T., Kumari, Y., Othman, I., & Williams, L. L. (2018) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2018.06.00212 · Cited by 4
Leal‐Junior, E. C. P., Casalechi, H. L., Machado, C. D. S. M., Serin, A., Hageman, N. S., & Johnson, D. S. (2019) · Journal of Biotechnology and Biomedical Science · doi:10.14302/issn.2576-6694.jbbs-19-2784 · Cited by 4
Distribution of Psychotropic Drugs Into Lipoproteins
Serkland, T. T., Schjøtt, J. D., Berg, J. A., Herfindal, L., Riedel, B., & Skrede, S. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000660 · Cited by 2
Thompson, S., Johnson, D. S., Lindgren, T. G., Compton, L., & Chen, J. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000478 · Cited by 2
“Research indicates that up to 70% of individuals taking antidepressant medications self-discontinue their medication due to intolerable side effects that include, but are not limited to, sexual dysfunction, weight gain, sleep disturbance, and excessive sweating (Ferguson, 2001).”
BackgroundTreatment of Suicidal Behavior for Inpatients
de Winter, R. F. P., Meijer, C. M., & de Groot, M. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-41319-4_67-1 · Cited by 2
A systematic review on the use of phytotherapy in managing clinical depression
Fazilat, S., Tahmasbi, F., Mirzaei, M., Sanaie, S., Yousefi, Z., Asnaashari, S., Yaqoubi, S., Mohammadi, A. B., & Araj‐Khodaei, M. (2024) · Bioimpacts · doi:10.34172/bi.30532 · Cited by 9
“49 Patients may be drawn to phytotherapeutic treatments because they are perceived to have fewer side effects and be gentler on the body.”
BackgroundAstrocyte-derived dominance winning reverses chronic stress-induced depressive behaviors
Noh, K., Oh, J., Cho, W.-H., Hwang, M., & Lee, S. J. (2024) · Molecular Brain · doi:10.1186/s13041-024-01134-1 · Cited by 4
The effects of antidepressants on gastric ulcer
Güneş, M. L. (2013) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2013.04.0362 · Cited by 2
“SSRI ilaçlar 5HT2 ve 5HT3 reseptörlerinin uyarılmasına ve ekstrasellüler seratonin artışına sebep olurlar [61].”
Elbakry, K., Alazabi, N. I., Omer, N. M., Bahnasawy, M. H., & Ahmed-Farid, O. A.-H. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i9.566 · Cited by 2
Event-Related Potential Correlates of Social and Nonsocial Cognitive Processes Related to Schizotypy
Davidson, C. A. (2015) · Lincoln (University of Nebraska) · Cited by 2
Für jeden Patienten den optimalen Wirkstoff finden: Antidepressive Pharmakotherapie
Lieb, M., Rupprecht, R., & Baghai, T. C. (2012) · NeuroTransmitter · doi:10.1007/s15016-012-0565-x · Cited by 2
Uçkun, Z., Başkak, B., Özdemir, H., Ozel-Kizil, E. T., Özgüven, H. D., & Suzen, H. S. (2016) · Turkish Journal of Pharmaceutical Sciences · doi:10.5505/tjps.2016.29484 · Cited by 2
“Thus, 5-HTT is the first candidate of approaching a genetic predictor of response to SSRIs.”
ResultInfluentialFactors That Impact Choice of Antidepressant Treatment in Medically Complex Patients
Dago, P. L. (2009) · CNS Spectrums · doi:10.1017/s1092852900026377 · Cited by 2
Pharmacological and Pharmaceutical Profiling: New Trends
Bowes, J., Rolf, M. G., Valentin, J., Hamon, V., Crawford, M. S., & Jean, T. (2006) · CRC Press eBooks · doi:10.1201/9781420004236-10 · Cited by 2
Blampied, M., Bell, C., Gilbert, C., Boden, J. M., Nicholls, R. J., & Rucklidge, J. J. (2018) · Medicines · doi:10.3390/medicines5020056 · Cited by 3
Psychopharmacology in Pediatric Mixed Anxiety Disorder: An Evidence-based Review.
Naveed, S., Amray, A. N., Jahan, N., Motiwala, F., & Majeed, M. H. (2019) · PubMed · Cited by 2
Pharmacological and Pharmaceutical Profiling
Rolf, M. G., Crawford, M. S., Hamon, V., Bowes, J., Valentin, J., & Jean, T. (2006) · Informa Healthcare eBooks · doi:10.1201/9781420004236.ch6 · Cited by 2
Saffron in Phytotherapy: Pharmacological Properties and Medicinal Uses
Zouagui, R., & Sbabou, L. (2022) · Compendium of plant genomes · doi:10.1007/978-3-031-10000-0_15 · Cited by 5
Lim, J. O., Kim, M. J., Bae, J. B., Jeon, C. H., Han, J. H., Sim, T. H., & Kim, Y. (2023) · Journal of Korean Biological Nursing Science · doi:10.7586/jkbns.23.345 · Cited by 2
Oh, S. J., Lee, N., Nam, K. R., Kang, K. J., Han, S. J., & Choi, J. Y. (2023) · Molecular Imaging and Biology · doi:10.1007/s11307-023-01825-6 · Cited by 3
“Fluoxetine has good therapeutic effects; however, some patients still experience adverse effects, such as nausea, sleep disturbance, and headache [24].”
BackgroundTension-type headache – most prevalent, still unknown
Sobieski, M., & Korzeniewska, A. (2019) · World Scientific News · Cited by 2
Umarudeen, A. M., & Magaji, M. G. (2020) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2020/v14i230123 · Cited by 2
“These are in addition to neurobehavioural effects such as insomnia, akathisia, agitation, sexual dysfunction and cognitive decline even on a short-term basis [8-11].”
BackgroundGündoğar, D., Demirci, S., & Uluhan, F. (2007) · International journal of psychiatry in clinical practice · doi:10.1080/13651500601127149 · Cited by 1
“In the second part, 15 frequently encountered side effects of SSRIs were listed [26] (Appendix 2).”
BackgroundLiu, F., & Yin, X. (2025) · Research Square · doi:10.21203/rs.3.rs-6178867/v1 · Cited by 2
Visser, G. P. (2012) · Boloka Institutional Repository (North-west University) · Cited by 2
Psychiatric Comorbidities in HIV Infection
Thames, A. D., & Jones, J. D. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_12 · Cited by 2
Treatment of Suicidal Behavior for Inpatients
de Winter, R. F. P., Meijer, C. M., & de Groot, M. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-42003-1_67 · Cited by 1
Signal detection of adverse events associated with gabapentinoid use for chronic pain
Kuo, Y., Polychronopoulou, E., & Raji, M. A. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5685 · Cited by 1
John, N., Ferri, F. A., Brito, E. M., Devineni, M. N., & Newman, M. I. (2025) · Cureus · doi:10.7759/cureus.79639 · Cited by 3
“Common side effects of SSRIs include gastrointestinal (GI) disturbances, anxiety, agitation, insomnia, sexual dysfunction, and weight gain, with citalopram being the best-tolerated drug followed by fluoxetine, sertraline, paroxetine, and fluvoxamine [10].”
Umbrio, L. R. N., Pham, H. M., Barmak, A. B., Assery, N. M., & Kotsailidi, E. A. (2025) · Evidence-Based Dentistry · doi:10.1038/s41432-025-01179-8 · Cited by 1
Pavlova, T. A., Telepina, M. A., Perelygin, V. V., Smetannikova, E. A., Sklyarova, N. A., & Orlova, A. V. (2025) · Pharmacy Formulas · doi:10.17816/phf686915 · Cited by 3
Xi, C., Jiang, X., He, Y., Liu, Y., An, H., Shang, K., Ma, X., & Ren, D. (2025) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v53i4.1963 · Cited by 2
“Sertraline acts by blocking the reuptake of the neurotransmitter serotonin by neurons, thereby increasing the concentration of serotonin in the synaptic gap and enhancing neurotransmission to improve depressive symptoms [14].”
Christoforou, L., & Sutcliffe, K. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-13445-7 · Cited by 2
“Non-indicated long-term ADM use may increase risks of adverse effects which are often underreported in clinical trials [19, 20], the severity of which vary within and across different ADM types [21–23].”
Antidepressant medications: a comprehensive review of efficacy, safety, and future directions
Shah, N., Parmar, J., Shandilya, S., Parmar, D., & Singhal, P. K. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20253726 · Cited by 3
A unifying theory of brain signaling and its possible role in acquired chronic disease
Pereira, G., Corbett, M., Vernon, S. D., Colburn, S., & Chanda, S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1683413 · Cited by 1
“Before compensatory action, literally any side eect is possible (Ferguson, 2001; Warden et al., 2010; Andrews et al., 2012; Carvalho et al., 2016; Anagha et al., 2021; Edino et al., 2021), including alterations in neuromuscular control (Gönül and Aksu, 1999; FIGURE 2 CRF (green dots) and…”
Robinson, J., Wallace, N., Cassidy, E. K., Lake, S., & Lucas, P. (2026) · Contemporary Drug Problems · doi:10.1177/00914509261444382 · Cited by 1
“…notoriously dif fi cult to treat, as traditional antidepressants take weeks or months to work, are effective in only 30% – 40% of patients, and often provide only partial relief, require prolonged use, and cause adverse side effects (Artin et al., 2021; Ferguson, 2001; Marazziti et al., 2019).”
Ding, X., Murayama, R., Cai, Y., Yue, Y., Yang, J., & Hashimoto, K. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04117-z · Cited by 1
“Although antidepressant medications remain a cornerstone of treatment, their clinical utility is often limited by delayed therapeutic onset, incomplete symptom remission, and adverse effects that reduce adherence [7 – 12].”
Laino, L. V., Mascolo, A., Napoli, R. D., di Mauro, G., Vastarella, M. G., Capuano, A., & Rafaniello, C. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02378-9 · Cited by 1
Differential Diagnosis of Abnormal Symptoms and Signs
Ettinger, A. B., & Weisbrot, D. M. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.003 · Cited by 1
Acupuncture and Moxibustion in Animal Models of Cancer
Zhang, R.-X., & Lao, L. (2012) · Evidence-based anticancer complementary and alternative medicine · doi:10.1007/978-94-007-4833-0_13 · Cited by 1
Insomnia: assessment and treatment review
Qazi, F. M., & Schluederberg, E. A. (2012) · Osteopathic Family Physician · doi:10.1016/j.osfp.2012.03.002 · Cited by 1
“Selective serotonin reuptake inhibitors (SSRIs) generally disrupt sleep continuity, decrease TST, suppress REM, and increase N1 sleep.(61) The serotonin modulator trazodone is sedative through histamine-1 and 5-HT2 receptor antagonism.”
BackgroundImpact of antidepressant treatment: a study from The Netherlands
van Dongen, N., & Mason (2012) · Patient Intelligence · doi:10.2147/pi.s33613 · Cited by 1
“As a consequence of their overall safety, efficacy, and tolerability profiles, they are widely prescribed by primary care physicians.(7) In this study, 82% of patients were prescribed SSRIs/SNRIs (see Table 2).”
InfluentialPeh, A. L. H., Nieng, C. H., Yap, H. L., Kheng, T. W., Tan, S. N., & Koon, O. G. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2012.12.009 · Cited by 1
Metabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats
Annamária, I., Kolcsár, M., Groșan, A., Imre, M., & Dogaru, M. T. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0049 · Cited by 1
“The advantage of these new types of drugs consists not necessarily in their higher effectiveness, but especially in their considerably decreased risk of side effects [4].”
BackgroundKoshy, B., Hosur, S. S., Jose, S., Rajashekarachar, Y., & Das, G. (2016) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.9.2.14 · Cited by 1
Justman, S. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137523297_4 · Cited by 2
Are selective serotonin reuptake inhibitors associated with fractures?
Drost, S., & Massicotte, A. (2016) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163516671744 · Cited by 1
“, citalopram, paroxetine, sertraline) are one of the most widely used classes of antidepressants because of their efficacy, favourable side effect profile and broad indications for use.(2) In the past decade, more attention has been paid to the adverse effects of medications on bone health.”
BackgroundMetabolische Nebenwirkungen von Psychopharmaka
Zeiss, R., Connemann, B. J., & Gahr, M. (2017) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-017-1494-0 · Cited by 1
Repetitive transcranial magnetic stimulation versus sham therapy in major depression
Varghese, A., George, G., Radhakrishnan, R. V., Vinnetha, R., Kaimal, R., & Jose, S. P. (2018) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2018.7.1.14 · Cited by 1
Psychopharmakotherapie und metabolische Nebenwirkungen
Connemann, B. J., Gahr, M., & Zeiss, R. (2017) · Nervenheilkunde · doi:10.1055/s-0038-1627514 · Cited by 2
“Untersuchungen zeigen jedoch, dass eine Langzeittherapie mit SSRI ebenfalls ein Risikofaktor für eine Zunahme des Körpergewichts darstellt (36).”
BackgroundSystematic analysis of drug combinations that mitigate adverse drug reactions
Shim, J., Luo, H., Zhang, P., & Li, Y. (2018) · IBM Journal of Research and Development · doi:10.1147/jrd.2018.2875837 · Cited by 1
“SSRI is a class of drug used to treat major depressive disorder (MDD) and the common side effects associated are Gastrointestinal (GI) disturbances, anxiety, agitation, insomnia, sexual dysfunction, weight gain, and sleep disturbance [11].”
BackgroundCitalopram-Associated Alopecia: A Case Report and Brief Literature Review
Hekmatjah, J., Tareen, K., & Tareen, R. S. (2019) · Current Drug Safety · doi:10.2174/1574886314666190215115857 · Cited by 1
Depression in the elderly and psychobiotics
Vaghef‐Mehrabany, E., Ebrahimi‐Mameghani, M., Sanayei, M., & Vaghef‐Mehrabany, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00044-5 · Cited by 3
Gould, C. E., Edelstein, B. A., & Ciliberti, C. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1320-3_20 · Cited by 1
Role of Medicinal Plants in Combating Anti-depressant Induced Male Infertility
Raval, M., Gori, P., Patel, S. G., & Vyas, N. Y. (2022) · Current Traditional Medicine · doi:10.2174/2215083808666220321144217 · Cited by 3
The Development and Mechanism of Treatment of Depression
Chang, F., Kuang, X., & Liu, Y. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v8i.1120 · Cited by 1
Karataş, Y., Khan, Z., & Khan, F. U. (2022) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.1112770 · Cited by 1
Effect of psychotropics on bleeding and clotting factors
Roy, P., Khar, P. B., Karia, S., Shah, N., & Desousa, A. (2022) · Acta Haematologica Polonica · doi:10.5603/ahp.a2022.2050 · Cited by 1
Escitalopram-induced akathisia in a patient with major depressive disorder: A rare case report
Arshad, H., Sana, S., Sajnani, P. K., Owolabi, O. J., & Anand, A. (2022) · SAGE Open Medical Case Reports · doi:10.1177/2050313x221139710 · Cited by 2
Systematic Review of The Efficacy of Korean Ginseng in Men with Erectile Dysfunction
Putri, R. M., Hinting, A., Harsoyo, P. M., & Nugrahanti, F. R. (2023) · Indonesian Andrology and Biomedical Journal · doi:10.20473/iabj.v4i1.44796 · Cited by 1
Stevenson, B., Gavrilidis, E., Malik, Y., & Kulkarni, J. (2024) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2024.101297 · Cited by 2
“Despite these promising findings, many individuals report common side effects of SSRIs, which may preclude their use and result in discontinuation despite clinical efficacy [14,30].”
BackgroundHammer, T., Kotolová, H., Procházka, J. H., & Karpíšek, M. (2024) · Pharmacology · doi:10.1159/000541229 · Cited by 2
“The impact of citalopram and other SSRI antide-pressants on body weight is uncertain as they may initially reduce weight but are more prone to causing weight gain in long-term clinical studies [5, 6, 8, 19, 20].”
Li, D., Mohanty, S., Mavathur, R. N., Vageesh, V. Y., Jain, A., Gopi, A., & Nagarathna, R. (2024) · Cureus · doi:10.7759/cureus.69240 · Cited by 4
Gamne, R., Wajpeyi, S. M., & Rai, M. (2024) · F1000Research · doi:10.12688/f1000research.139473.3 · Cited by 2
Schuurman, L. J. M., Sobczak, S., Schulkens, J. E. M., Balter, B. P. F., & van Alphen, S. P. J. (2025) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70009 · Cited by 1
“Fourth, different baseline characteristics (e.g., the number and dosage of psychotropic medication used) between the two subsamples may have influenced the overall factor structure (Ferguson 2001; Steckenrider 2023).”
Association of Psychiatric Illness or Psychotropic Medication Usage with Calcaneus Fracture
Janney, C., Goodrum, J., Jupiter, D. C., Wigg, C., & Carmichael, K. D. (2017) · Cureus · doi:10.7759/cureus.1977 · Cited by 1
Meeting the Mental Health Challenges of the Elder Boom
Friedman, M. B., Nestadt, P. S., Furst, L., & Williams, K. A. (2017) · Routledge eBooks · doi:10.4324/9781315690346-7 · Cited by 1
Bridges, A. J., Ledesma, R. J., Dueweke, A. R., Rodríguez, J. H., Anastasia, E. A., & Rojas, S. M. (2019) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09642-2 · Cited by 1
“However, some medications, even newer medications that are more tolerable to patients, have unwanted side effects such as headaches, nausea, gastrointestinal discomfort, weight gain, sexual dysfunction, and sleep disturbance that can interfere with treatment adherence, especially when used over a long period of time (…”
BackgroundOuellet, M., Beaulieu‐Bonneau, S., Savard, J., & Morin, C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811316-5.00001-x · Cited by 1
Wilson, C. (2020) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12623 · Cited by 1
Evaluation of Antidepressant Potential of Hydrastis canadensis in Mice
Batool, S., Saeed, H., Yehya, S., Ali, R., Mofreh, A., & Saeed, H. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4903 · Cited by 1
“SSRIs are used more commonly, but are associated with side effects such as drowsiness, diarrhea, insomnia, restlessness, and sexual problems [5].”
BackgroundThe effect of psychological and medical conditions on sexuality
Rokach, A., & Patel, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819174-3.00006-1 · Cited by 1
Monitoring Adverse Effects of Antipsychotics and Antidepressants: A Population Based Study
Rallabandi, S. S., Makula, S. S., Sindgi, V. M., Babu, B. J., & Puneem, U. S. (2021) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.14.3.38 · Cited by 1
“18 Thus in patients with existing cardiovascular diseases should not be prescribed with SNRI’s.”
Obsessive-Compulsive and Related Disorders
Hudak, R., & Gannon, J. M. (2022) · Current clinical practice · doi:10.1007/978-3-030-98709-1_6 · Cited by 1
Psilocybin Therapy for Major Depressive Disorder: A Systematic Review
Venugopal, K. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.489 · Cited by 3
TRICYCLIC AND SSRI USAGE INFLUENCES THE ASSOCIATION BETWEEN BMI AND HEALTH RISK FACTORS
Carlton, K. J. (2014) · YorkSpace (York University) · Cited by 2
Hard-to-diagnose headache: practical tips for diagnosis and treatment.
Beck, E. (2013) · PubMed · Cited by 2
McCluskey, D. L. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6192 · Cited by 3
Sustained Modulation of Deep Brain Circuits with Focused Ultrasonic WavesPreprint
Webb, T. D., Wilson, M. G., Odéen, H., & Kubanek, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4310447 · Cited by 1
The effects of sildenafil on neuroplasticity in human neuroblastoma cells
Reay, R. (2010) · Boloka Institutional Repository (North-west University) · Cited by 2
DFP: Antidepressive Pharmakotherapie: Aktueller Stand und neue Entwicklungen
Baghai, T., Hp, V., & Hj, M. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Zhang, B., Hao, Y., Li, X., Ren, Y., Zhou, P., & Liu, W. (2013) · Sleep and Biological Rhythms · doi:10.1111/sbr.12015
Assessing Sexual Function of Patients Before Initiating SSRI Therapy
Berigan, T. R. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0407a
The Folly of Systems: The Satiric Tradition and Mental Disorders
Justman, S. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137523297_7
Zirngibl, C. (2014) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000154
“Serotonergic side effects of SSRIs [64] are mentioned above and summarized in Table 3.”
BackgroundPereira, L. R. L., & Cesarino, E. J. (2006)
Should nonpharmacological treatments of anxiety be considered first systematically?
Belleville, G., & Provencher, M. D. (2011) · Neuropsychiatry · doi:10.2217/npy.10.6
SSRIs and Weight Gain: Balancing Outcomes for Optimal Management
Adams, C. (2012) · Research Exchange (Washington State University)
Correlation study of SSRIs drugs in Sexual Dysfunction
Moghadamnia, M., Nabavi, S. M., & Afshin‐Majd, S. (2013)
Caraci, F., & Sciascio, G. D. (2015) · Cited by 2
In Silico-Guided Design of Novel-Scaffold Therapeutics Targeting the Dopamine D3 Receptor
Hailemicael, D. G. (2014)
Distribution of serotonin transporters in the human hypothalamus
Borgers, A. J., Bisschop, P. H. L. T., Fliers, E., & Alkemade, A. (2011) · 13th European Congress of Endocrinology
Metadata
- Authors
- Ferguson, J. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Ferguson, James M.
- ORCID
- Ferguson, James M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-01
- Volume
- 3
- Issue
- 1
- Pages
- 22-27
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- PMC
- PMC181155
- OpenAlex
- W2024985387
- Cited by
- 669
- References
- 23
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 33 · 2023: 46 · 2022: 63 · 2021: 69 · 2020: 56 · 2019: 64 · 2018: 45 · 2017: 47 · 2016: 36 · 2015: 28 · 2014: 27 · 2013: 24 · 2012: 11
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, antidepressant side effects, sexual dysfunction, weight gain, sleep disorders, depression treatment, primary care management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.